Comparative Pharmacology
Head-to-head clinical analysis: NULYTELY versus PLENVU.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NULYTELY versus PLENVU.
NULYTELY vs PLENVU
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Polyethylene glycol (PEG) 3350 is an osmotic agent that induces diarrhea by drawing water into the gastrointestinal tract, thereby cleansing the bowel. Sodium sulfate and electrolytes (sodium, potassium, bicarbonate) are added to prevent fluid and electrolyte shifts.
PLENVU is an osmotic laxative that induces bowel cleansing by causing water retention in the colon, leading to increased intraluminal pressure and stimulation of peristalsis. Its components (polyethylene glycol 3350, sodium ascorbate, ascorbic acid, sodium sulfate) act synergistically to produce a cathartic effect.
4 liters orally of the reconstituted solution as a single dose for colonoscopy preparation, typically administered in divided doses (e.g., 240 mL every 10 minutes) until rectal effluent is clear. Alternatively, a split-dose regimen: half the solution evening before, half on the day of procedure.
2 sachets (each containing ascorbic acid 4.7g, macrogol 3350 52.5g, sodium ascorbate 5.9g, sodium sulfate 3.75g) dissolved in water to a total volume of 500mL, administered orally as a split-dose regimen: first dose (2 sachets in 500mL water) at 6-9 pm on the day before colonoscopy, followed by additional 500mL of clear fluids; second dose (2 sachets in 500mL water) on the morning of colonoscopy, completed at least 2 hours before the procedure, followed by additional 500mL of clear fluids.
None Documented
None Documented
Not applicable; NULYTELY is not systemically absorbed in significant amounts, so a terminal elimination half-life is not defined. The drug acts locally in the gastrointestinal tract.
Not applicable (non-absorbed agent); systemic absorption is minimal, so no terminal half-life is defined.
NULYTELY (polyethylene glycol 3350) is minimally absorbed systemically (<0.06%). The primary route of elimination is fecal excretion of the intact polymer. Renal excretion is negligible (<0.02%).
Primarily fecal (90-95%) as unabsorbed drug; renal excretion is negligible (<1%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative